Assignee
NOVAVAX INC
US·53 granted patents·32 pending applications·1,378 citations·filing 1994–2025
Top patents by PatentIndex Score
85 records- 0199US10953089B1Coronavirus vaccine formulationsNOVAVAX INC·Filed 2020·Granted Mar 23, 2021·99 cites·20 claims
- 0298US11541112B2Coronavirus vaccine formulationsNOVAVAX INC·Filed 2021·Granted Jan 3, 2023·5 cites·20 claims
- 0397US10022437B2Modified RSV F proteins and methods of their useNOVAVAX INC·Filed 2015·Granted Jul 17, 2018·22 cites·16 claims
- 0497US7763450B2Functional influenza virus-like particles (VLPs)NOVAVAX INC·Filed 2006·Granted Jul 27, 2010·48 cites·18 claims
- 0596US12357684B2Modified RSV F proteins and methods of their useNOVAVAX INC·Filed 2022·Granted Jul 15, 2025·2 cites·14 claims
- 0696US11896664B2Corona virus vaccine formulationsNOVAVAX INC·Filed 2022·Granted Feb 13, 2024·2 cites·34 claims
- 0796US11253586B2Coronavirus vaccine formulationsNOVAVAX INC·Filed 2021·Granted Feb 22, 2022·4 cites·26 claims
- 0896US11253585B2Vaccine compositions having improved stability and immunogenicityNOVAVAX INC·Filed 2019·Granted Feb 22, 2022·8 cites·27 claims
- 0996US5629021AMicellar nanoparticlesNOVAVAX INC·Filed 1995·Granted May 13, 1997·277 cites·12 claims
- 1095US10426829B2Vaccine compositions having improved stability and immunogenicityNOVAVAX INC·Filed 2016·Granted Oct 1, 2019·17 cites·14 claims
- 1194US9050290B2Functional influenza virus like particles (VLPs)NOVAVAX INC·Filed 2013·Granted Jun 9, 2015·18 cites·36 claims
- 1293US9180180B2Functional influenza virus-like particles (VLPs)NOVAVAX INC·Filed 2014·Granted Nov 10, 2015·15 cites·25 claims
- 1393US5549901AAntimicrobial oil-in-water emulsionsNOVAVAX INC·Filed 1994·Granted Aug 27, 1996·140 cites·11 claims
- 1493US5547677AAntimicrobial oil-in-water emulsionsNOVAVAX INC·Filed 1994·Granted Aug 20, 1996·144 cites·12 claims
- 1592US11446374B2Modified RSV F proteins and methods of their useNOVAVAX INC·Filed 2019·Granted Sep 20, 2022·5 cites·12 claims
- 1692US11052146B2Modified RSV F proteins and methods of their useNOVAVAX INC·Filed 2018·Granted Jul 6, 2021·3 cites·20 claims
- 1792US9675685B2Modified RSV F proteins and methods of their useNOVAVAX INC·Filed 2014·Granted Jun 13, 2017·11 cites·15 claims
- 1891US9731000B2Modified RSV F proteins and methods of their useNOVAVAX INC·Filed 2015·Granted Aug 15, 2017·7 cites·18 claims
- 1991US9717786B2Modified RSV F proteins and methods of their useNOVAVAX INC·Filed 2015·Granted Aug 1, 2017·7 cites·17 claims
- 2091US9623104B2Functional influenza virus-like particles (VLPS)NOVAVAX INC·Filed 2015·Granted Apr 18, 2017·7 cites·15 claims
- 2191US9474799B2Functional influenza virus-like particles (VLPS)NOVAVAX INC·Filed 2015·Granted Oct 25, 2016·8 cites·10 claims
- 2291US5618840AAntibacterial oil-in-water emulsionsNOVAVAX INC·Filed 1995·Granted Apr 8, 1997·102 cites·9 claims
- 2390US9694066B2Functional influenza virus like particles (VLPs)NOVAVAX INC·Filed 2015·Granted Jul 4, 2017·6 cites·16 claims
- 2489US9937253B2Functional influenza virus-like particles (VLPS)NOVAVAX INC·Filed 2017·Granted Apr 10, 2018·5 cites·15 claims
- 2589US9464276B2Highly efficient influenza matrix (M1) proteinsNOVAVAX INC·Filed 2015·Granted Oct 11, 2016·8 cites·16 claims
- 2688US12491241B2Coronavirus vaccine formulationsNOVAVAX INC·Filed 2023·Granted Dec 9, 2025·0 cites·11 claims
- 2788US11364294B2Vaccine compositions having improved stability and immunogenicityNOVAVAX INC·Filed 2017·Granted Jun 21, 2022·2 cites·24 claims
- 2887US7041500B2Insect cell lineNOVAVAX INC·Filed 2003·Granted May 9, 2006·12 cites·9 claims
- 2987US5700679ALipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activityNOVAVAX INC·Filed 1996·Granted Dec 23, 1997·86 cites·61 claims
- 3086US11278612B2Multivalent influenza nanoparticle vaccinesNOVAVAX INC·Filed 2019·Granted Mar 22, 2022·3 cites·20 claims
- 3186US5662957AOil containing lipid vesicles with marine applicationsNOVAVAX INC·Filed 1996·Granted Sep 2, 1997·67 cites·21 claims
- 3285US12472246B2Coronavirus vaccine formulationsNOVAVAX INC·Filed 2022·Granted Nov 18, 2025·0 cites·12 claims
- 3385US9956280B2Functional influenza virus-like particles (VLPs)NOVAVAX INC·Filed 2016·Granted May 1, 2018·3 cites·8 claims
- 3485US6387373B1Vaccines containing paucilsmellar lipid vesicles as immunological adjuvantsNOVAVAX INC·Filed 1997·Granted May 14, 2002·74 cites·8 claims
- 3583US5795582AAdjuvant properties of poly (amidoamine) dendrimersNOVAVAX INC·Filed 1996·Granted Aug 18, 1998·63 cites·16 claims
- 3683US5730989AOral vaccine against gram negative bacterial infectionNOVAVAX INC·Filed 1995·Granted Mar 24, 1998·64 cites·26 claims
- 3782US12257297B2Vaccine compositions having improved stability and immunogenicityNOVAVAX INC·Filed 2022·Granted Mar 25, 2025·0 cites·30 claims
- 3882US11123419B2Methods and compositions for inducing immune responses against Clostridium difficileNOVAVAX INC·Filed 2018·Granted Sep 21, 2021·1 cites·22 claims
- 3982US10188723B2Functional influenza virus like particles (VLPs)NOVAVAX INC·Filed 2017·Granted Jan 29, 2019·2 cites·17 claims
- 4082US9381239B2VLPS derived from cells that do not express a viral matrix or core proteinNOVAVAX INC·Filed 2014·Granted Jul 5, 2016·2 cites·21 claims
- 4180US12083228B2Methods and compositions for treating respiratory diseaseNOVAVAX INC·Filed 2018·Granted Sep 10, 2024·1 cites·18 claims
- 4277US2024423926A1Methods and compositions for treating respiratory diseaseNOVAVAX INC·Filed 2024·Application pending·0 cites
- 4375US9951317B2Highly efficient influenza matrix (M1) proteinsNOVAVAX INC·Filed 2016·Granted Apr 24, 2018·1 cites·20 claims
- 4475US2024293530A1Multivalent influenza nanoparticle vaccinesNOVAVAX INC·Filed 2024·Application pending·0 cites
- 4574US10751410B2Immunogenic middle east respiratory syndrome coronavirus (MERS-CoV) compositions and methodsNOVAVAX INC·Filed 2014·Granted Aug 25, 2020·1 cites·18 claims
- 4674US7393541B2Mycobacterial vaccineNOVAVAX INC·Filed 2004·Granted Jul 1, 2008·10 cites·11 claims
- 4770US11938179B2Methods and compositions for inducing immune responses against Clostridium difficileNOVAVAX INC·Filed 2021·Granted Mar 26, 2024·0 cites·20 claims
- 4870US11896662B2Multivalent influenza nanoparticle vaccinesNOVAVAX INC·Filed 2021·Granted Feb 13, 2024·0 cites·12 claims
- 4969US10729760B2Functional influenza virus like particles (VLPs)NOVAVAX INC·Filed 2018·Granted Aug 4, 2020·0 cites·15 claims
- 5068US2025325646A1Compositions and methods for inducing an immune response against epstein-barr virusNOVAVAX INC·Filed 2023·Application pending·0 cites
Showing the top 50 of 85 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when NOVAVAX INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →